Adjuvia Therapeutics

Adjuvia Therapeutics is a biotech company in San Francisco, United States, founded in 2023. It has raised $8.0M across 1 round, most recently an $8.0M Seed in July 2026.

Harnessing the Power of Nature’s Designs

Headquarters
San Francisco
Employees
1–10
Founded
2023
Business Model
B2B
Total Funding
$8.0M
Last Round
$8.0M SeedJul 2026
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 1 funding round for this company. The full record is or through the API.

About

Adjuvia Therapeutics is a clinical-stage biopharmaceutical company developing blood-brain-barrier-penetrant nanoparticle therapies for diseases associated with mitochondrial dysfunction. Its lead program, ATI-105, is an oral nanoparticle formulation of astaxanthin designed to address rare and chronic degenerative conditions at their underlying cellular mechanisms. The company is advancing therapies for inherited mitochondrial diseases and evaluating additional chronic-disease indications.

Summary

It lists 1–10 employees. It has raised $8.0M in total across 1 round, most recently a $8.0M Seed round in Jul 2026.

Tech & App Stack

1 technology or app tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
SeedJul 2026
$8.0M

Similar Companies

Paratek PharmaceuticalsAcquired

Paratek Pharmaceuticals develops and delivers innovative treatments for serious infectious diseas...

Boston, United States201–500Biotech, Healthcare
ConvertibleTotal funding$1.8BApr 2018
Sana BiotechnologyIPO

Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

Seattle, United States201–500Biotech, Healthcare
Series DTotal funding$1.4BJun 2020
Abogen Biosciences

Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...

Suzhou, China201–500Biotech, Drug Discovery
Extension RoundTotal funding$1.2BNov 2021
Alnylam PharmaceuticalsIPO

Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...

Cambridge, United States1001–5000Biotech, Genomics
Corporate RoundTotal funding$1.0BApr 2020
Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Adjuvia Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/adjuvia-therapeutics"><img src="https://indexed.vc/api/badge/company/adjuvia-therapeutics" alt="Adjuvia Therapeutics on Indexed.vc" width="260" height="76" /></a>